Scope of the Report:

The global Impetigo Treatment market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024.

The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.

North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Impetigo Treatment.

Europe also play important roles in global market, with market size of xx million USD in 2019 and will be xx million USD in 2024, with a CAGR of xx%.

This report studies the Impetigo Treatment market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Impetigo Treatment market by product type and applications/end industries.

Market Segment by Companies, this report covers

Ranbaxy Laboratories Limited

Roche Holding AG

Lupin Limited

Karalex Pharma, LLC

GlaxoSmithKline plc

Leo Pharma A/S

Taro Pharmaceutical Industries Ltd

Pfizer, Inc.

NovaBay Pharmaceuticals, Inc.

SANDOZ GmbH

Teva Pharmaceutical Industries Ltd

Market Segment by Regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

South America (Brazil, Argentina, Colombia)

Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

Cephalosporins

Fusidane

Lincosamide Antibiotic

Penicillin

Penicillin-Like Antibiotics

Pleuromutilin

Pseudomonic Acid A

Quinolone

Sulfonamides And Folic Acid Inhibitors

Tetracyclines

Market Segment by Applications, can be divided into

Hospitals

Clinic

Others

Table of Contents

1 Impetigo Treatment Market Overview

1.1 Product Overview and Scope of Impetigo Treatment

1.2 Classification of Impetigo Treatment by Types

1.2.1 Global Impetigo Treatment Revenue Comparison by Types (2019-2024)

1.2.2 Global Impetigo Treatment Revenue Market Share by Types in 2018

1.2.3 Cephalosporins

1.2.4 Fusidane

1.2.5 Lincosamide Antibiotic

1.2.6 Penicillin

1.2.7 Penicillin-Like Antibiotics

1.2.8 Pleuromutilin

1.2.9 Pseudomonic Acid A

1.2.10 Quinolone

1.2.11 Sulfonamides And Folic Acid Inhibitors

1.2.12 Tetracyclines

1.3 Global Impetigo Treatment Market by Application

1.3.1 Global Impetigo Treatment Market Size and Market Share Comparison by Applications (2014-2024)

1.3.2 Hospitals

1.3.3 Clinic

1.3.4 Others

1.4 Global Impetigo Treatment Market by Regions

1.4.1 Global Impetigo Treatment Market Size (Million USD) Comparison by Regions (2014-2024)

1.4.1 North America (USA, Canada and Mexico) Impetigo Treatment Status and Prospect (2014-2024)

1.4.2 Europe (Germany, France, UK, Russia and Italy) Impetigo Treatment Status and Prospect (2014-2024)

1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Impetigo Treatment Status and Prospect (2014-2024)

1.4.4 South America (Brazil, Argentina, Colombia) Impetigo Treatment Status and Prospect (2014-2024)

1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Impetigo Treatment Status and Prospect (2014-2024)

1.5 Global Market Size of Impetigo Treatment (2014-2024)

2 Company Profiles

2.1 Ranbaxy Laboratories Limited

2.1.1 Business Overview

2.1.2 Impetigo Treatment Type and Applications

2.1.2.1 Product A

2.1.2.2 Product B

2.1.3 Ranbaxy Laboratories Limited Impetigo Treatment Revenue, Gross Margin and Market Share (2017-2018)

2.2 Roche Holding AG

2.2.1 Business Overview

2.2.2 Impetigo Treatment Type and Applications

2.2.2.1 Product A

2.2.2.2 Product B

2.2.3 Roche Holding AG Impetigo Treatment Revenue, Gross Margin and Market Share (2017-2018)

2.3 Lupin Limited

2.3.1 Business Overview

2.3.2 Impetigo Treatment Type and Applications

2.3.2.1 Product A

2.3.2.2 Product B

2.3.3 Lupin Limited Impetigo Treatment Revenue, Gross Margin and Market Share (2017-2018)

2.4 Karalex Pharma, LLC

2.4.1 Business Overview

2.4.2 Impetigo Treatment Type and Applications

2.4.2.1 Product A

2.4.2.2 Product B

2.4.3 Karalex Pharma, LLC Impetigo Treatment Revenue, Gross Margin and Market Share (2017-2018)

2.5 GlaxoSmithKline plc

2.5.1 Business Overview

2.5.2 Impetigo Treatment Type and Applications

2.5.2.1 Product A

2.5.2.2 Product B

2.5.3 GlaxoSmithKline plc Impetigo Treatment Revenue, Gross Margin and Market Share (2017-2018)

2.6 Leo Pharma A/S

2.6.1 Business Overview

2.6.2 Impetigo Treatment Type and Applications

2.6.2.1 Product A

2.6.2.2 Product B

2.6.3 Leo Pharma A/S Impetigo Treatment Revenue, Gross Margin and Market Share (2017-2018)

2.7 Taro Pharmaceutical Industries Ltd

2.7.1 Business Overview

2.7.2 Impetigo Treatment Type and Applications

2.7.2.1 Product A

2.7.2.2 Product B

2.7.3 Taro Pharmaceutical Industries Ltd Impetigo Treatment Revenue, Gross Margin and Market Share (2017-2018)

2.8 Pfizer, Inc.

2.8.1 Business Overview

2.8.2 Impetigo Treatment Type and Applications

2.8.2.1 Product A

2.8.2.2 Product B

2.8.3 Pfizer, Inc. Impetigo Treatment Revenue, Gross Margin and Market Share (2017-2018)

2.9 NovaBay Pharmaceuticals, Inc.

2.9.1 Business Overview

2.9.2 Impetigo Treatment Type and Applications

2.9.2.1 Product A

2.9.2.2 Product B

2.9.3 NovaBay Pharmaceuticals, Inc. Impetigo Treatment Revenue, Gross Margin and Market Share (2017-2018)

2.10 SANDOZ GmbH

2.10.1 Business Overview

2.10.2 Impetigo Treatment Type and Applications

2.10.2.1 Product A

2.10.2.2 Product B

2.10.3 SANDOZ GmbH Impetigo Treatment Revenue, Gross Margin and Market Share (2017-2018)

2.11 Teva Pharmaceutical Industries Ltd

2.11.1 Business Overview

2.11.2 Impetigo Treatment Type and Applications

2.11.2.1 Product A

2.11.2.2 Product B

2.11.3 Teva Pharmaceutical Industries Ltd Impetigo Treatment Revenue, Gross Margin and Market Share (2017-2018)

3 Global Impetigo Treatment Market Competition, by Players

3.1 Global Impetigo Treatment Revenue and Share by Players (2014-2019)

3.2 Market Concentration Rate

3.2.1 Top 5 Impetigo Treatment Players Market Share

3.2.2 Top 10 Impetigo Treatment Players Market Share

3.3 Market Competition Trend

4 Global Impetigo Treatment Market Size by Regions

4.1 Global Impetigo Treatment Revenue and Market Share by Regions

4.2 North America Impetigo Treatment Revenue and Growth Rate (2014-2019)

4.3 Europe Impetigo Treatment Revenue and Growth Rate (2014-2019)

4.4 Asia-Pacific Impetigo Treatment Revenue and Growth Rate (2014-2019)

4.5 South America Impetigo Treatment Revenue and Growth Rate (2014-2019)

4.6 Middle East and Africa Impetigo Treatment Revenue and Growth Rate (2014-2019)

5 North America Impetigo Treatment Revenue by Countries

5.1 North America Impetigo Treatment Revenue by Countries (2014-2019)

5.2 USA Impetigo Treatment Revenue and Growth Rate (2014-2019)

5.3 Canada Impetigo Treatment Revenue and Growth Rate (2014-2019)

5.4 Mexico Impetigo Treatment Revenue and Growth Rate (2014-2019)

6 Europe Impetigo Treatment Revenue by Countries

6.1 Europe Impetigo Treatment Revenue by Countries (2014-2019)

6.2 Germany Impetigo Treatment Revenue and Growth Rate (2014-2019)

6.3 UK Impetigo Treatment Revenue and Growth Rate (2014-2019)

6.4 France Impetigo Treatment Revenue and Growth Rate (2014-2019)

6.5 Russia Impetigo Treatment Revenue and Growth Rate (2014-2019)

6.6 Italy Impetigo Treatment Revenue and Growth Rate (2014-2019)

7 Asia-Pacific Impetigo Treatment Revenue by Countries

7.1 Asia-Pacific Impetigo Treatment Revenue by Countries (2014-2019)

7.2 China Impetigo Treatment Revenue and Growth Rate (2014-2019)

7.3 Japan Impetigo Treatment Revenue and Growth Rate (2014-2019)

7.4 Korea Impetigo Treatment Revenue and Growth Rate (2014-2019)

7.5 India Impetigo Treatment Revenue and Growth Rate (2014-2019)

7.6 Southeast Asia Impetigo Treatment Revenue and Growth Rate (2014-2019)

8 South America Impetigo Treatment Revenue by Countries

8.1 South America Impetigo Treatment Revenue by Countries (2014-2019)

8.2 Brazil Impetigo Treatment Revenue and Growth Rate (2014-2019)

8.3 Argentina Impetigo Treatment Revenue and Growth Rate (2014-2019)

8.4 Colombia Impetigo Treatment Revenue and Growth Rate (2014-2019)

9 Middle East and Africa Revenue Impetigo Treatment by Countries

9.1 Middle East and Africa Impetigo Treatment Revenue by Countries (2014-2019)

9.2 Saudi Arabia Impetigo Treatment Revenue and Growth Rate (2014-2019)

9.3 UAE Impetigo Treatment Revenue and Growth Rate (2014-2019)

9.4 Egypt Impetigo Treatment Revenue and Growth Rate (2014-2019)

9.5 Nigeria Impetigo Treatment Revenue and Growth Rate (2014-2019)

9.6 South Africa Impetigo Treatment Revenue and Growth Rate (2014-2019)

10 Global Impetigo Treatment Market Segment by Type

10.1 Global Impetigo Treatment Revenue and Market Share by Type (2014-2019)

10.2 Global Impetigo Treatment Market Forecast by Type (2019-2024)

10.3 Cephalosporins Revenue Growth Rate (2014-2024)

10.4 Fusidane Revenue Growth Rate (2014-2024)

10.5 Lincosamide Antibiotic Revenue Growth Rate (2014-2024)

10.6 Penicillin Revenue Growth Rate (2014-2024)

10.7 Penicillin-Like Antibiotics Revenue Growth Rate (2014-2024)

10.8 Pleuromutilin Revenue Growth Rate (2014-2024)

10.9 Pseudomonic Acid A Revenue Growth Rate (2014-2024)

10.10 Quinolone Revenue Growth Rate (2014-2024)

10.11 Sulfonamides And Folic Acid Inhibitors Revenue Growth Rate (2014-2024)

10.12 Tetracyclines Revenue Growth Rate (2014-2024)

11 Global Impetigo Treatment Market Segment by Application

11.1 Global Impetigo Treatment Revenue Market Share by Application (2014-2019)

11.2 Impetigo Treatment Market Forecast by Application (2019-2024)

11.3 Hospitals Revenue Growth (2014-2019)

11.4 Clinic Revenue Growth (2014-2019)

11.5 Others Revenue Growth (2014-2019)

12 Global Impetigo Treatment Market Size Forecast (2019-2024)

12.1 Global Impetigo Treatment Market Size Forecast (2019-2024)

12.2 Global Impetigo Treatment Market Forecast by Regions (2019-2024)

12.3 North America Impetigo Treatment Revenue Market Forecast (2019-2024)

12.4 Europe Impetigo Treatment Revenue Market Forecast (2019-2024)

12.5 Asia-Pacific Impetigo Treatment Revenue Market Forecast (2019-2024)

12.6 South America Impetigo Treatment Revenue Market Forecast (2019-2024)

12.7 Middle East and Africa Impetigo Treatment Revenue Market Forecast (2019-2024)

13 Research Findings and Conclusion

14 Appendix

14.1 Methodology

14.2 Data Source

List of Tables and Figures

Figure Impetigo Treatment Picture

Table Product Specifications of Impetigo Treatment

Table Global Impetigo Treatment and Revenue (Million USD) Market Split by Product Type<